Lyka Labs Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Lyka Labs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
25.90% Fall from 52W High
-4.4
TTM PE Ratio
Negative PE TTM
-147
Price to Book Ratio
Below industry Median
5.2
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-1.8
RSI
RSI is mid-range
45.6
MFI
MFI is mid-range
35.1

Lyka Labs Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Lyka Labs Ltd shareholding Pattern

Promoter
54.8%
Foreign Institutions
0.2%
Domestic Institutions
0.9%
Public
44.1%
Promoter
54.8%
Foreign Institutions
0.2%
Domestic Institutions
0.6%
Public
44.4%
Promoter
54.8%
Foreign Institutions
0.2%
Domestic Institutions
0.4%
Public
44.6%
Promoter
54.6%
Foreign Institutions
0.2%
Domestic Institutions
0.4%
Public
44.8%
Promoter
51%
Foreign Institutions
0.2%
Mutual Funds
3.3%
Domestic Institutions
3.7%
Public
45.1%
Promoter
47.6%
Foreign Institutions
0.4%
Mutual Funds
3.5%
Domestic Institutions
4%
Public
48%

Lyka Labs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
107.70
10Day EMA
107.80
12Day EMA
107.90
20Day EMA
108.80
26Day EMA
109.70
50Day EMA
112.60
100Day EMA
115.60
200Day EMA
117.20
5Day SMA
107.90
10Day SMA
107.70
20Day SMA
107.60
30Day SMA
109.80
50Day SMA
115.50
100Day SMA
117.90
150Day SMA
120.00
200Day SMA
118.50
Delivery & Volume
Resistance & Support
107.72
Pivot
Resistance
First Resistance
110.14
Second Resistance
112.42
Third Resistance
114.84
Support
First Support
105.44
Second support
103.02
Third Support
100.74
Relative Strength Index
45.55
Money Flow Index
35.08
MACD
-1.76
MACD Signal
-2.24
Average True Range
4.62
Average Directional Index
30.92
Rate of Change (21)
-3.91
Rate of Change (125)
-11.81
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Ambalal Sarabhai Enterprises Ltd.
-
-
-
Jenburkt Pharmaceuticals Ltd.
-
-
-
Kerala Ayurveda Ltd.
-
-
-
Zenotech Laboratories Ltd.
-
-
-
Fredun Pharmaceuticals Ltd.
-
-
-
Medico Remedies Ltd.
323.72
35
92.87

Lyka Labs Ltd Company background

Founded in: 1976
Initially manufacturing formulations, Lyka Labs brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. 83. It also added a range of ayurvedic and animal health care products over the years. In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US Airsep Corporation, US Coloplast, Denmark and Terumo Corporation, Japan. Lyka Exports is the subsidiary of the company. The company offers a broad range of antibiotics used as lifesavers and to treat minor infections. It has a fairly widespread product base with tropical steroids for skin disorders, anticancer products, cardiovascular drugs and antiinflammatory products. Lyka introduced, in India, cough lozenges containing dextromethorphan hydrobromide (DMR), favoured internationally as an effective and safe cough suppressant. Lyka has two formulations division and a bulk drugs division. It also set up additional manufacturing facilities for ointments. As part of its diversification, it has invested in Relic Finance, a company carrying on the business of finance and merchant banking.A GOIrecognised Export House, it received the Certificate of Merit for its excellent export performance in 199394. In the same year, it received an award from CHEMEXCIL for its outstanding performance.During 199798, the companys administrative office plant at tarapur has been awarded ISO 9002 certification for its quality management system by SGS Yarsley International Certification Services Limited, UK.The production carried out at Bombay has been shifted to Tarapur and Ankleshwar in the year 19992000, inorder to achieve economies of scale and better compliance. The company has assigned Trade Marks and transferred technical, marketing knowhow and allied rights pertaining to some of its products.The Companys factory at Tarapur, recommissioned production in March, 2013. It launched Glutathione Injection, a First Time in India formulation during 201213. It commissioned the production at Ankleshwar factory. During Financial Year 201314, the Company had floated a Wholly Owned Subsidiary Company namely Lyka Healthcare Limited to focus, develop and expand Domestic Marketing of Ethical Products. Its another subsidiary, Lyka Exports Limited reorganized its activities and resultant, it sold the Animal Healthcare Business in 2014. The subsidiaries, Lyka Healthcare Limited and Lyka Exports Limited merged with the Company which became effective from April 01, 2016. During the year 202122, IPCA together with persons acting in concert acquired 26.70% shares of the Company through Public Offer consisting a total shareholding of 27.76% of the Paidup Equity Capital of the Company and resultant to acquisition in stake, became the Joint Promoters of Company.
Read More

Lyka Labs Ltd FAQs

The past 1-year return of Lyka Labs Ltd [LYKALABS] share was -6.68. The Lyka Labs Ltd [LYKALABS] share hit a 1-year low of Rs. 99.95 and a 1-year high of Rs. 143.5.

The Mutual Fund Shareholding was 0.01% at the end of .

You can easily buy Lyka Labs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage